Hospital acquired infection control market reaches $16 billion

The global hospital acquired infection control market was worth about $16.0 billion in 2016, says the latest report of Kalorama Information. The figure includes testing products, device sterilisation, specific cleaning products and HAI treatments. The healthcare market research firm’s report, Hospital Acquired Infection (HAI) Control Markets, provides market analysis for the prevention, diagnosis, and treatment segments of such infections.

“The infection control market is a probable growth market for some time,” says Bruce Carlson, publisher of Kalorama Information (a specialist division of marketresearch.com). “There will always be a need to control these infections, as many of the bacteria that cause infection evolve and develop resistance to antimicrobials. New approaches to preventing, diagnosing, and treating such infections will be required for the long-term.”

Advertisements